YIN Shankai  

  • Chief Physician, Doctoral Supervisor, Professor
  • Department: ENT & HN Surgery
  • Research Area: Otolaryngology
  • Research Interests: Prevention and treatment of deafness, vertigo and OSAHS
  • Contact: yinshankai@china.com
  • MD from Chinese People's Liberation Army Medical School, 1995
  • President, Shanghai Sixth People's Hospital
  • Director, Shanghai Key Laboratory of Sleep Disordered Breathing
  • Director, Otolaryngology Institute of Shanghai Jiao Tong University
  • President, International Association of Physicians in Audiology-China Chapter
  1. Zhu YD, Ma XY, Li LP, Yang QJ, Jin F, Chen ZN, Wu CP, Shi HB, Feng ZQ, Yin SK, Li CY. Surface Functional Modification by Ti3 C2 Tx MXene on PLLA Nanofibers for Optimizing Neural Stem Cell Engineering. Adv Healthc Mater. 2023 Oct;12(25):e2300731. doi: 10.1002/adhm.202300731.
  2. Liu HW, Gong LN, Lai K, Yu XF, Liu ZQ, Li MX, Yin XL, Liang M, Shi HS, Jiang LH, Yang W, Shi HB, Wang LY, Yin SK. Bilirubin gates the TRPM2 channel as a direct agonist to exacerbate ischemic brain damage. Neuron. 2023 May 17;111(10):1609-1625.e6. doi: 10.1016/j.neuron.2023.02.022. 
  3. Cui Y, Wu C, Li L, Shi H, Li C, Yin S. Toward nanotechnology-enabled application of bilirubin in the treatment and diagnosis of various civilization diseases. Mater Today Bio. 2023 May 4;20:100658. doi: 10.1016/j.mtbio.2023.100658. 
  4. Xu H, Liu F, Li Z, Li X, Liu Y, Li N, Zhang X, Gao Z, Zhang X, Liu Y, Zou J, Meng L, Liu S, Zhu H, Tang X, Wu H, Su K, Chen B, Yu D, Ye H, Chen H, Yi H, Yin S, Guan J, Shi Y. Genome-Wide Association Study of Obstructive Sleep Apnea and Objective Sleep-related Traits Identifies Novel Risk Loci in Han Chinese Individuals. Am J Respir Crit Care Med. 2022 Dec 15;206(12):1534-1545. doi: 10.1164/rccm.202109-2044OC. 
  5. Li C, Xiong Z, Zhou L, Huang W, He Y, Li L, Shi H, Lu J, Wang J, Li D, Yin S. Interfacing Perforated Eardrums with Graphene-Based Membranes for Broadband Hearing Recovery. Adv Healthc Mater. 2022 Oct;11(20):e2201471. doi: 10.1002/adhm.202201471. 
  • 01/02/2024-31/12/2028
    National Natural Science Foundation of China (Key Program), ¥2,200,000, 82330034
    The mechanism of Calpain activation in noise induced cochlear injury caused by mitochondrial homeostasis imbalance
    Role: Project leader
  • 01/01/2023-31/12/2025
    Medicine-Engineering Interdisciplinary Key Research Project of Shanghai Jiao Tong University, ¥2,000,000, YG2023LC11
    Development and clinical validation of a new intelligent multi-channel sleep diagnosis system
    Role: Project leader
  • 31/12/2021-30/11/2026
    Innovation 2030- Major Science and Technology Projects, ¥13,600,000, 2021ZD0201903
    Research on key genes and regulatory networks of sleep disorders
    Role: Project leader
  1. [Yumeng Jiang, Dongzhen Yu, Shankai Yin, Zhuangzhuang Li, Qingxiu Yao] (2023), “Application of Yao Ye Coral glycoside in the prevention or treatment of cisplatin ototoxicity”, ZL 2022 11142058.0
  2. [Jian Guan, Shankai Yin, Hongliang Yi, Bin Sheng, Huating Li, Ruhan Liu, Huajun Xu] (2022), “Method, device, computer equipment, and storage medium for analyzing blood oxygen saturation signals”, ZL 2020 10003990.X
  3. [Shankai Yin, Dongzhen Yu, Jianrong Zhou, Qin Li] (2019), “Human dizziness treatment device”, ZL 2016 100648 16.X